Press Room

Event

Webinar Series: Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management

Start
Tuesday, February 28, 2023 - 16:00
End
Thursday, April 20, 2023 - 17:00
Location: online
Webinar Series Spray Drying - SEM image of a particle in a dark green background

Hovione presents a new comprehensive three-part webinar series on "Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management" starting February 28, 2023.

Over the course of this series, Hovione experts will guide you through the complete journey of amorphous solid dispersions (ASDs), starting from the early formulation stage to process development and scale-up, and finally to commercial reality and lifecycle management of ASDs. 
As an experienced manufacturer of ASDs by spray drying for the pharmaceutical industry, Hovione will be able to share its extensive knowledge and experience. Furthermore, the featured experts will be available to answer your questions during a live Q&A.

 

Key Learnings for the Webinar Series

  • Gain knowledge on designing a successful formulation for Amorphous Solid Dispersions produced by Spray Drying
  • Discover how to develop a robust process at lab scale and assure a successful scale-up
  • Learn how to use a model-based methodology to establish the design space and a commercial process
  • Understand what to consider during the Lifecycle Management of a commercial Amorphous Solid Dispersion by Spray Drying 

 

SESSION 1 (On-demand)
Evaluating the Best Formulations for Amorphous Solid Dispersions by Spray Drying

Register Now to join us | Hovione
/press-room/events/webinar-evaluating-best-formulations-amorphous-solid-dispers…

 

SESSION 2 (On-demand)
ASDs by Spray Drying: Process Development & Scale-Up

Register Now to join us | Hovione
/press-room/events/webinar-asds-spray-drying-process-development-scale

 

SESSION 3 (On-demand)
Commercial Reality and Lifecycle Management of ASDs

Register Now to join us | Hovione
https://www.hovione.com/press-room/events/webinar-commercial-reality-and-lifecy…

 

 

Do you have a challenging project?

get in touch with us click here | Hovione
http://go.hovione.com/l/47122/2014-08-06/9grc

Schedule your individual meeting at the upcoming tradeshows and conferences in Berlin, Boston, Orlando, Barcelona, Delhi or Edinburgh.

 

 

 

Also in the Press Room

See All

CDMO Hovione and biotechnology company Firstgene Life Sciences (of Xlife Sciences) have collaborated to advance Hovione’s drug delivery platform for the targeted treatment of Hepatocellular Carcinoma (HCC). “We are proud to advance the development of innovative oncology treatments that address a critical unmet need for precision gene expression at the tissue level,” said Hovione CEO Dr Jean-Luc Herbeaux. The virus-like particle technology will be engineered and functionalised for the specific carcinoma cell type using therapeutically validated AAVs, including a novel primer compound. Hovione will be responsible for molecular engineering, the supply of tailor-made virus-like particles and the execution of proof-of-concept studies. “HCC, the most common liver cancer and a leading cause of cancer-related death, continues to represent a major unmet medical need,” said Firstgene managing director Dr Alexander Zink. “The combination of Hovione’s expertise in complex chemistry and particle engineering and the commercialisation expertise of Xlife Sciences positions Firstgene well to offer patients potential new safe and effective therapy options.”   Read the full article at scientistlive.com    

Press Clipping
Scientist Live, 12 May 2025

Partnership advances liver cancer treatment

May 12, 2025

Dear Customer, As you may be aware, Portugal and Spain experienced yesterday, April 28 (at approximately 11:30) a widespread power outage. This unexpected event, beyond our control, affected the normal activities at our sites in Portugal. In response, we promptly activated our contingency protocols for this type of situation, prioritizing the safety of facilities and personnel. All ongoing processes were taken to safe hold points, and no new processes were initiated. Our backup power generators ensured continuity of critical functions throughout the duration of the outage, which lasted approximately 11 hours, until the power from the grid was restored at the site. The site began resuming operations gradually through the night making sure all systems being restarted safely and verified to be in good working conditions. We anticipate that most activities will be fully resumed during today. Should you have any specific questions regarding your product or project, we kindly encourage you to contact your Account Manager or Project Manager, who will be glad to assist you. We sincerely appreciate your understanding and continued partnership.      

News
News release, 29 April 2025

Widespread power outage in Portugal - Message to our clients

Apr 29, 2025

In a recent appearance on CNN Portugal’s Pitch – Brand & Content program, Ilda Ventura, Senior Vice President of Human Resources at Hovione, highlighted a powerful reality: 55% of our employees in Science, Technology, Engineering, and Mathematics (STEM) roles are women. At Hovione, we’re proud to foster an environment where women in science thrive - leading innovation, driving progress, and shaping the future of healthcare. But our commitment goes beyond numbers - it’s about creating the right conditions for scientific talent to grow, equally and globally. “I am proud to say that, in our company, there is no gender pay gap between men and women. We empower everyone. Our female and male scientists are all working to find more sustainable, faster, and more productive ways to achieve victories over diseases.” - Ilda Ventura Watch the full edition to learn more about our commitment to women in science at CNNPortugal.pt  (Language: Portuguese)  

Press Clipping
CNN Portugal, 15 March 2025

Ilda Ventura broadcasted on CNN Portugal

Mar 15, 2025

Also in Events

See All